Cargando…
Enhancing Antitumor Efficacy by Simultaneous ATP‐Responsive Chemodrug Release and Cancer Cell Sensitization Based on a Smart Nanoagent
The exploitation of smart nanoagents based drug delivery systems (DDSs) has proven to be a promising strategy for fighting cancers. Hitherto, such nanoagents still face challenges associated with their complicated synthesis, insufficient drug release in tumors, and low cancer cell chemosensitivity....
Autores principales: | Song, Xiao‐Rong, Li, Shi‐Hua, Guo, Hanhan, You, Wenwu, Tu, Datao, Li, Juan, Lu, Chun‐Hua, Yang, Huang‐Hao, Chen, Xueyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299707/ https://www.ncbi.nlm.nih.gov/pubmed/30581711 http://dx.doi.org/10.1002/advs.201801201 |
Ejemplares similares
-
Ultrasensitive Point‐of‐Care Test for Tumor Marker in Human Saliva Based on Luminescence‐Amplification Strategy of Lanthanide Nanoprobes
por: Zhou, Shanyong, et al.
Publicado: (2021) -
Efficient intracellular delivery makes cancer cells sensitive to nanoemulsive chemodrugs
por: Liu, Shan, et al.
Publicado: (2017) -
Analysis of the Reversible Impact of the Chemodrug Busulfan on Mouse Testes
por: Thirouard, Laura, et al.
Publicado: (2021) -
A Strategy of NIR Dual‐Excitation Upconversion for Ratiometric Intracellular Detection
por: Ke, Jianxi, et al.
Publicado: (2019) -
Single-molecular phosphorus phthalocyanine-based near-infrared-II nanoagent for photothermal antitumor therapy
por: Zhou, Li-Na, et al.
Publicado: (2020)